E
ReShape Lifesciences Inc. RSLS
$0.6355 $0.00050.08%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -16.55% -23.00% -24.82% -22.79% -13.01%
Total Other Revenue -- -- -- -- --
Total Revenue -16.55% -23.00% -24.82% -22.79% -13.01%
Cost of Revenue -42.16% -39.56% -33.49% -29.47% 4.80%
Gross Profit 5.16% -11.28% -19.37% -18.44% -23.96%
SG&A Expenses -45.96% -47.33% -47.13% -39.10% -31.29%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -42.04% -42.67% -41.95% -35.80% -25.74%
Operating Income 55.94% 53.09% 50.36% 41.63% 31.23%
Income Before Tax 73.27% 74.56% 73.60% 75.67% 60.93%
Income Tax Expenses 288.57% 115.71% 113.13% 113.68% 94.36%
Earnings from Continuing Operations 72.98% 74.09% 73.21% 75.36% 60.61%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 72.98% 74.09% 73.21% 75.36% 60.61%
EBIT 55.94% 53.09% 50.36% 41.63% 31.23%
EBITDA 54.39% 50.54% 46.98% 36.82% 27.69%
EPS Basic 91.23% 51.00% -47.73% -- --
Normalized Basic EPS 90.26% 59.06% -34.34% -- --
EPS Diluted 91.23% 51.00% -47.73% -- --
Normalized Diluted EPS 90.26% 59.06% -34.34% -- --
Average Basic Shares Outstanding 1,012.90% 1,261.75% 2,562.37% -- --
Average Diluted Shares Outstanding 1,012.90% 1,261.75% 2,562.37% -- --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings